Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: final results of a noninterventional studyLothar Bergmann, Michael Staehler, Ulrich Kube et al.|BMC Cancer|2015Cited by 23
Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional StudyLothar Bergmann, Christian Doehn, Steffen Weikert et al.|Oncology Research and Treatment|2013Cited by 15
Everolimus as second-line therapy for metastatic renal cell carcinoma (mRCC) after one previous VEGF-targeted therapy: Final results of the noninterventional change study.Peter J. Goebell, Lothar Bergmann, Ulrich Kube et al.|Journal of Clinical Oncology|2014Cited by 5
Das nicht-kleinzellige Lungenkarzinom – Status Quo 2012Christoph‐Thomas Germer, Ingo Hartlapp, Hermann Einsele et al.|Unknown|2013Cited by 0
Vol. 36, Issue 3, March 2013 / Band 36, Heft 3, Marz 2013Christoph‐Thomas Germer, Ingo Hartlapp, Hermann Einsele et al.|Onkologie|2013Cited by 0